Posted December 26, 2017: by Bill Sardi
Dermatologists report the use of a common blood pressure drug, the diuretic (water pill) hydrochlorothiazide, increases the risk for skin cancer. The risk for non-melanoma skin cancers (basal cell carcinoma, squamous cell carcinoma) rose significantly with increasing doses of this anti-hypertension drug.
It is already known that all three major classes of drugs used to control elevated blood pressure deplete zinc.
It has recently been reported that zinc supplementation reduces the risk for skin cancer under experimental conditions in the animal laboratory.
Physicians diagnose rough skin, poor appetite, mental lethargy, abnormal dark adaptation, hair loss (alopecia), diarrhea, emotional disorders, weight loss (anorexia), chronic infections, copper overload (Wilson’s disease), loss of taste and smell, and hypogonadism in males when aggregately they represent an umbrella disease emanating from a shortage of zinc.
It has been over 50 years now since the discovery that zinc is an essential nutrient to maintain health and no campaign has begun to quell the problem that emanates in humans as eye disease, viral and other immune disorders, growth retardation and diarrhea in children, copper overload, mental and behavioral problems and many skin conditions.
What escapes recognition is that over-supply of zinc can induce zinc deficiency. For example, 100-milligram zinc supplementation results in a doubling of the risk for prostate cancer compared to non-zinc users. Yet zinc has also been found to halt the growth of cancer. Mega-dose zinc supplementation induces a binding protein (metallothionein) that blocks the bioavailability of zinc.
Posted in Cancer, Dietary Supplements, Minerals ; No Comments »
11
17
52
95
14
24
237
6
56
43
10
116
15
66
105